|
OMIM |
Link |
Information gain |
01 |
|
SCAR2
|
[NCBI]
|
0.00209383
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
0.000599634
|
|
|
IDDM
|
[NCBI]
|
0.000327626
|
|
|
TLR3
|
[NCBI]
|
0.000284568
|
|
|
STAT1
|
[NCBI]
|
0.000237065
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00023368
|
|
|
IL28RA
|
[NCBI]
|
0.000144153
|
|
|
IRF3
|
[NCBI]
|
0.000137723
|
|
|
TNF
|
[NCBI]
|
0.000126428
|
|
|
TBK1
|
[NCBI]
|
0.000125178
|
|
|
virus-induced signaling adaptor
|
[NCBI]
|
0.000116606
|
|
|
PDB
|
[NCBI]
|
0.000112325
|
|
|
IRF5
|
[NCBI]
|
9.68115e-05
|
|
|
TLR7
|
[NCBI]
|
8.71615e-05
|
|
|
SDS
|
[NCBI]
|
7.52887e-05
|
|
|
camptomelic syndrome, long-limb type
|
[NCBI]
|
7.4356e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
7.4356e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
7.4356e-05
|
|
|
IL29
|
[NCBI]
|
7.20285e-05
|
|
|
IL28B
|
[NCBI]
|
7.20285e-05
|
|
|
IL28A
|
[NCBI]
|
7.20285e-05
|
|
|
HDAC1
|
[NCBI]
|
6.54838e-05
|
|
|
TLR9
|
[NCBI]
|
6.06201e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
5.92121e-05
|
|
|
EV
|
[NCBI]
|
5.89239e-05
|
|
|
TRAF3
|
[NCBI]
|
5.82548e-05
|
|
|
GZMM
|
[NCBI]
|
5.82548e-05
|
|
|
TLR8
|
[NCBI]
|
5.82548e-05
|
|
|
FGL2
|
[NCBI]
|
5.82548e-05
|
|
|
FRA16A
|
[NCBI]
|
5.78732e-05
|
|
|
RNASE2
|
[NCBI]
|
5.67431e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
5.54931e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
5.31929e-05
|
|
|
CXADR
|
[NCBI]
|
5.30604e-05
|
|
|
TNFRSF4
|
[NCBI]
|
5.30604e-05
|
|
|
TNFRSF18
|
[NCBI]
|
5.30604e-05
|
|
|
GZMK
|
[NCBI]
|
4.96897e-05
|
|
|
IL10RB
|
[NCBI]
|
4.96897e-05
|
|
|
IFIH1
|
[NCBI]
|
4.96897e-05
|
|
|
CPB1
|
[NCBI]
|
4.7185e-05
|
|
|
EA2
|
[NCBI]
|
4.7123e-05
|
|
|
CJD
|
[NCBI]
|
4.58802e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
4.52907e-05
|
|
|
IRF7
|
[NCBI]
|
4.51904e-05
|
|
|
ICSBP1
|
[NCBI]
|
4.51904e-05
|
|
|
DFFA
|
[NCBI]
|
4.35329e-05
|
|
|
EFE
|
[NCBI]
|
4.26498e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
4.2172e-05
|
|
|
IRAK4
|
[NCBI]
|
4.2115e-05
|
|
|
RNASE3
|
[NCBI]
|
4.15155e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
4.08762e-05
|
|
|
HLA-G
|
[NCBI]
|
3.97765e-05
|
|
|
IFNAR1
|
[NCBI]
|
3.87878e-05
|
|
|
CXCL13
|
[NCBI]
|
3.87878e-05
|
|
|
TCRG
|
[NCBI]
|
3.78899e-05
|
|
|
PDCD1
|
[NCBI]
|
3.78899e-05
|
|
|
CD44
|
[NCBI]
|
3.70676e-05
|
|
|
HLA-DRA
|
[NCBI]
|
3.63093e-05
|
|
|
STAT4
|
[NCBI]
|
3.56057e-05
|
|
|
DM2
|
[NCBI]
|
3.51451e-05
|
|
|
RIPK1
|
[NCBI]
|
3.43349e-05
|
|
|
MHS1
|
[NCBI]
|
3.29538e-05
|
|
|
SLE
|
[NCBI]
|
3.13097e-05
|
|
|
SOCS1
|
[NCBI]
|
3.12934e-05
|
|
|
CCL21
|
[NCBI]
|
3.08681e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
3.08271e-05
|
|
|
IBD1
|
[NCBI]
|
2.93659e-05
|
|
|
CTLA4
|
[NCBI]
|
2.89855e-05
|
|
|
HLA-A
|
[NCBI]
|
2.86497e-05
|
|
|
IL2
|
[NCBI]
|
2.72268e-05
|
|
|
JMML
|
[NCBI]
|
2.66658e-05
|
|
|
HMGB1
|
[NCBI]
|
2.63208e-05
|
|
|
TLR4
|
[NCBI]
|
2.3784e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.34537e-05
|
|
|
SOD2
|
[NCBI]
|
2.27885e-05
|
|
|
MAP3K5
|
[NCBI]
|
2.18869e-05
|
|
|
HS
|
[NCBI]
|
2.11201e-05
|
|
|
TERT
|
[NCBI]
|
1.90303e-05
|
|
|
CF
|
[NCBI]
|
1.81963e-05
|
|
|
BTK
|
[NCBI]
|
1.74376e-05
|
|
|
IFNA1
|
[NCBI]
|
1.47202e-05
|
|
|
AGER
|
[NCBI]
|
1.45808e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.44438e-05
|
|
|
RA
|
[NCBI]
|
1.31267e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.25729e-05
|
|
|
MBP
|
[NCBI]
|
1.06613e-05
|
|
|
RB1
|
[NCBI]
|
9.7049e-06
|
|
|
EGF
|
[NCBI]
|
9.58171e-06
|
|
|
CVID
|
[NCBI]
|
8.66178e-06
|
|
|
TPO
|
[NCBI]
|
7.62252e-06
|
|
|
GNRH1
|
[NCBI]
|
6.55391e-06
|
|
|
EGFR
|
[NCBI]
|
5.37592e-06
|
|
|
XDH
|
[NCBI]
|
5.20293e-06
|
|
|
MPO
|
[NCBI]
|
4.75295e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.76024e-06
|
|
|
FMF
|
[NCBI]
|
2.69867e-06
|
|
|
MG
|
[NCBI]
|
2.60604e-06
|
|
|
PCNA
|
[NCBI]
|
2.5576e-06
|
|
|
CHAT
|
[NCBI]
|
2.45219e-06
|
|
|
CD
|
[NCBI]
|
2.20999e-06
|
|
|
PWS
|
[NCBI]
|
2.10624e-06
|
|
|
AFP
|
[NCBI]
|
1.59258e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.19008e-06
|
|
|
GFAP
|
[NCBI]
|
1.14939e-06
|
|
|
PD
|
[NCBI]
|
8.30265e-07
|
|
|
TNFSF6
|
[NCBI]
|
7.98317e-07
|
|
|
G6PD
|
[NCBI]
|
4.99695e-07
|
|
|
F3
|
[NCBI]
|
4.52858e-07
|
|
|
NGFB
|
[NCBI]
|
3.58623e-07
|
|
|
CRH
|
[NCBI]
|
6.42883e-09
|
|